Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Voorberg

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Blood Advances|January 15, 2025
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTPTim Postmus, Nelly Schilder, Juliana Ferreira de Santana, et al.
Plos One|June 24, 2014
Individual with subclinical atherosclerosis have impaired proliferation of blood outgrowth endothelial cells, which can be restored by statin therapyJavier Martin-Ramirez, Maayke G M Kok, Menno Hofman, et al.
British Journal of Haematology|October 31, 2002
Analysis of factor VIII inhibitors in a haemophilia A patient with an Arg593-->Cys mutation using phage displayWendy S Bril, Ellen A M Turenhout, Paul H P Kaijen, et al.
Thrombosis and Haemostasis|September 6, 2006
Amino acid regions 572-579 and 657-666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTPBrenda M Luken, Ellen A M Turenhout, Paul H P Kaijen, et al.
Journal of Thrombosis and Haemostasis : JTH|April 15, 2023
Quantitative super-resolution imaging of platelet degranulation reveals differential release of von Willebrand factor and von Willebrand factor propeptide from alpha-granulesMaurice Swinkels, Sophie Hordijk, Petra E Bürgisser, et al.
British Journal of Haematology|March 29, 2002
Factor VIII inhibitor in a patient with mild haemophilia A and an Asn618-->Ser mutation responsive to immune tolerance induction and cyclophosphamideAndré J Vlot, Shulamiet Wittebol, Paul F W Strengers, et al.
Journal of Thrombosis and Haemostasis : JTH|November 7, 2024
The severe von Willebrand disease variant p.M771V leads to impaired anterograde trafficking of von Willebrand factor in patient-derived and base-edited endothelial colony-forming cellsIsabel Bär, Alastair Barraclough, Petra E Bürgisser, et al.
Haematologica|April 16, 2026
Establishing reverse chimeric antigen receptor T cells for precise targeting of immunemediated thrombotic thrombocytopenic purpuraRutuja S Gupte, Sara Rovira Puig, Liliana R Loureiro, et al.
Haematologica|January 7, 2017
Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular traffickingEduard H T M Ebberink, Eveline A M Bouwens, Esther Bloem, et al.
Haematologica|December 5, 2015
von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIIINicoletta Sorvillo, Robin B Hartholt, Esther Bloem, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Blood Advances|January 15, 2025
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTPTim Postmus, Nelly Schilder, Juliana Ferreira de Santana, et al.
Plos One|June 24, 2014
Individual with subclinical atherosclerosis have impaired proliferation of blood outgrowth endothelial cells, which can be restored by statin therapyJavier Martin-Ramirez, Maayke G M Kok, Menno Hofman, et al.
British Journal of Haematology|October 31, 2002
Analysis of factor VIII inhibitors in a haemophilia A patient with an Arg593-->Cys mutation using phage displayWendy S Bril, Ellen A M Turenhout, Paul H P Kaijen, et al.
Thrombosis and Haemostasis|September 6, 2006
Amino acid regions 572-579 and 657-666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTPBrenda M Luken, Ellen A M Turenhout, Paul H P Kaijen, et al.
Journal of Thrombosis and Haemostasis : JTH|April 15, 2023
Quantitative super-resolution imaging of platelet degranulation reveals differential release of von Willebrand factor and von Willebrand factor propeptide from alpha-granulesMaurice Swinkels, Sophie Hordijk, Petra E Bürgisser, et al.
British Journal of Haematology|March 29, 2002
Factor VIII inhibitor in a patient with mild haemophilia A and an Asn618-->Ser mutation responsive to immune tolerance induction and cyclophosphamideAndré J Vlot, Shulamiet Wittebol, Paul F W Strengers, et al.
Journal of Thrombosis and Haemostasis : JTH|November 7, 2024
The severe von Willebrand disease variant p.M771V leads to impaired anterograde trafficking of von Willebrand factor in patient-derived and base-edited endothelial colony-forming cellsIsabel Bär, Alastair Barraclough, Petra E Bürgisser, et al.
Haematologica|April 16, 2026
Establishing reverse chimeric antigen receptor T cells for precise targeting of immunemediated thrombotic thrombocytopenic purpuraRutuja S Gupte, Sara Rovira Puig, Liliana R Loureiro, et al.
Haematologica|January 7, 2017
Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular traffickingEduard H T M Ebberink, Eveline A M Bouwens, Esther Bloem, et al.
Haematologica|December 5, 2015
von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIIINicoletta Sorvillo, Robin B Hartholt, Esther Bloem, et al.
Pageof 16